InvestorsHub Logo
Followers 68
Posts 5584
Boards Moderated 0
Alias Born 01/13/2012

Re: srinsocal post# 216860

Thursday, 02/27/2020 11:47:04 AM

Thursday, February 27, 2020 11:47:04 AM

Post# of 330384
Easy to recall the run in 08 and 09 when BIEL ran from $.004 to $.129 on a bogus rumor that the company would receive FDA clearance in a few weeks.

Why no major run now, after recently receiving FDA general musculoskeletal clearance? Too many bungles by the former CEO, outrageous share structure, the toxicity of the Whelan name still in the forefront as a result of the former CEO since 2 out of 3 Directors on the BoD are Whelans, the former CEO said "No" to several of the major players in the pain space. Imagine defiantly bleating, "No" to Dr. Scholl's, CVS, KT Tape? Imagine allowing the CE Mark to expire! Imagine that history of bungling and not wanting to clean house instantly to reverse the negativity! Big players don't like red flages, imagine ignoring that fact! Oh baby!

Fix the share structure, fix the name toxicity, make 2 deals and watch the sp climb out of the toilet beautifully. Waiting for the 180 day deadline is just making it more difficult for Keith and Erin to make deals. Google BIEL and look at the red flags. Remove them and prove that stupidity, stubbornness, ego and pride are not managing the company. What's that? You don't want the sp at 5 cents? Rather stay in the toilet after 10 years? What!!!